Vaccine development: Man vs MRSA | Tiniest bioprobe breaks new size record | CDC pilot programs boost disease response in Uganda, Vietnam | 1,500-year-old plague victims shed light on disease origins | Intranasal vaccine protects mice against West Nile infection | A credible radioactive threat to Sochi Olympics? | FDA seeks input on draft approach for designating high-risk foods | Silk coat for diamonds makes sleek new drug delivery and imaging tool | Seven new H7N9 cases, plus family cluster, reported | Life after the military: Consider a career in public health | Ancient plague DNA revived from a 1,500-year-old tooth | Fight over diverting campaign funds for research takes new turn | Why does Syria still have 95 percent of its chemical weapons? | Investigational use of intravenous zanamivir for 2013-2014 flu season | New class of RNA drugs
See what we’re reading this week at Global Biodefense on topics threats to the Sochi Olympics, ancient plague DNA, H7N9 influenza updates and more…
Vaccine development: Man vs MRSA (Nature)
CDC pilot programs boost disease response in Uganda, Vietnam (CIDRAP)
1,500-year-old plague victims shed light on disease origins (Guardian)
Intranasal vaccine protects mice against West Nile infection (ASM)
A credible radioactive threat to Sochi Olympics? (FAS)
FDA seeks input on draft approach for designating high-risk foods (FSN)
Silk coat for diamonds makes sleek new drug delivery and imaging tool (Optical Society)
Seven new H7N9 cases, plus family cluster, reported (CIDRAP)
Ancient plague DNA revived from a 1,500-year-old tooth (NPR)
Fight over diverting campaign funds for research takes new turn (Science)
Why does Syria still have 95 percent of its chemical weapons? (NTI GSN)
Investigational use of intravenous zanamivir for 2013-2014 flu season (CDC)
New class of RNA drugs (EU Biotech News)
